MedPath

Found 556413 clinical trials

Sort by:

Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth

Not Applicable

Not yet recruiting

Conditions: Sleep

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Children's Hospital Los Angeles

Target Recruit Count: 1320

Registration Number: NCT07213908

Locations: 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Not Applicable

Recruiting

Conditions: Mycobacterium Avium Complex Pulmonary Disease

Interventions: Drug: Contezolid
Drug: Azithromycin
Drug: Ethambutol (E)
Drug: Rifampicin (R)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Bin Cao

Target Recruit Count: 188

Registration Number: NCT07213765

Locations: 🇨🇳
Anhui Chest Hospital, Hefei, Anhui, China
🇨🇳
Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Municipality, China
🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing Municipality, China

and more 3 locations

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)

Not Applicable

Not yet recruiting

Conditions: Postpartum Depression (PPD)
Parental Anxiety
Engagement, Patient
Self-Efficacy
Usability
Length of Stay

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 150

Registration Number: NCT07214597

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Using Plasma HPV Related DNA and RNA to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Not yet recruiting

Conditions: Cervical Cancer
Human Papilloma Virus (HPV)

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: University of Florida

Target Recruit Count: 55

Registration Number: NCT07214584

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

Not Applicable

Not yet recruiting

Conditions: Induction of Birth
Cervical Ripening
Cervical Ripening and Induction of Labor

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Aalto University

Target Recruit Count: 90

Registration Number: NCT07214948

InRAD Observational Study

Not yet recruiting

Conditions: Alzheimer's Disease(AD)
Mild Cognitive Impairment (MCI)
Subjective Cognitive Decline (SCD)
Non-Alzheimer Degenerative Dementia

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Stichting International Registry for Alzheimer's Disease and other Dementias Foundation

Target Recruit Count: 50000

Registration Number: NCT07213700

Youth Empowerment and Safety Intervention

Not Applicable

Not yet recruiting

Conditions: Suicide
Self-Injurious Behavior

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Case Western Reserve University

Target Recruit Count: 60

Registration Number: NCT07214233

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Not yet recruiting

Conditions: Venous Thromboembolism
Obese Patients

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 80

Registration Number: NCT07213713

Remimazolam vs Propofol in Laser Burn Cases

Not Applicable

Not yet recruiting

Conditions: Burn Scar
Hypertrophic Scarring
Procedural Sedation

Interventions: Drug: Remimazolam besylate
Drug: Propofol

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Medical University of South Carolina

Target Recruit Count: 136

Registration Number: NCT07213544

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Not Applicable

Not yet recruiting

Conditions: Geographic Atrophy Secondary to Age-related Macular Degeneration

Interventions: Drug: APL-2, Pegcetacoplan

First Posted Date: 2025-10-09

Last Posted Date: 2025-10-09

Lead Sponsor: Apellis Pharmaceuticals, Inc.

Target Recruit Count: 36

Registration Number: NCT07214740

AI-Powered Research

Premium Access

Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

NICU Utilization of Remote Voice Technology to Improve mateRnal Experience (NURTURE)

Using Plasma HPV Related DNA and RNA to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

InRAD Observational Study

Youth Empowerment and Safety Intervention

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Remimazolam vs Propofol in Laser Burn Cases

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Product

Company

Legal